MarketInOut Stock Screener Log In | Sign Up

Burning Rock Biotech Ltd ADR

NASDAQ • Healthcare • Diagnostics & Research • Quote as of 10/30/2026
Burning Rock Biotech Ltd ADR stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeNASDAQ
Market Capitalization114.96 mln
Float8.76 mln
Earnings Date11/17/2026

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-2.32
Borderline

Relative Strength

10 / 100
Significantly lagging

Debt / Equity

0.09
Debt-free

Pre-Tax Margin

-13%
Loss-making

ROE

-12.80
Negative

Business Description

Burning Rock Biotech, founded in 2014 and based in Guangzhou, China, develops advanced genetic testing tools that help doctors choose the right cancer treatments for their patients. The company serves hospitals, independent laboratories, and pharmaceutical companies across China and the United States, offering tests that analyze tumor DNA from both tissue and blood samples across a wide range of cancer types. It also partners with major global pharmaceutical companies to support clinical trials and drug development research.

Key Fundamentals

EPS-0.80
ROE-12.80
RPS69.30
ROIC-25.50
ROA-8.52
Interest Cover-1,084
EBITDA, mln-6.53
EV / EBITDA-10.19
EV / EBIT-7.00
Revenue, mln71.59
EV / Revenue0.93

Quote Details

Last 10.90
Change -0.15 (-1.36%)
Open 10.51
Volume 12,158
Turnover 132,522
Average Volume 24,725

Financial Ratios

Pre-Tax Profit Margin-13
Leverage Ratio1.51
Current Ratio3.03
Price / Book1.42
Price / Tangible Book1.42
Debt / Equity0.09
Price / Sales1.77

Financial Strength

Altman Z-Score-5.26
Piotroski F-Score 4 / 9
Beneish M-Score-2.32
Short Ratio1.13
Short % of Float0.52

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -7.78% 12 / 100   
1 Month -31.83% 11 / 100   
2 Months 15.96% 91 / 100   
6 Months -35.88% 18 / 100   
1 Year -11.09% 36 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog